• Explore /
  • Poster
  • / Relationship of bone marrow blast (BMBL) response to overall survival (OS) in a multicenter study of rigosertib (Rigo) in patients (pts) with myelodysplastic syndrome (MDS) with excess blasts progressing on or after treatment with a hypomethylating agent (HMA).

Relationship of bone marrow blast (BMBL) response to overall survival (OS) in a multicenter study of rigosertib (Rigo) in patients (pts) with myelodysplastic syndrome (MDS) with excess blasts progressing on or after treatment with a hypomethylating agent (HMA).

Abstract Poster

Authors

null

Aref Al-Kali

Mayo Clinic, Rochester, MN

Aref Al-Kali , Devendra Hiwase , Maria R. Baer , Peter Greenberg , Jake Shortt , Robert Collins , David P. Steensma , Amit Verma , Gail J. Roboz , Jamile M. Shammo , Oliver G. Ottmann , John Francis Seymour , Jeffrey Szer , Wolfgang Meyer , Patrick Simon Zbyszewski , Michael E. Petrone , Steven M. Fruchtman , Guillermo Garcia-Manero , Lewis R. Silverman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Myelodysplastic Syndromes (MDS)

Clinical Trial Registration Number

NCTO 1928537

Citation

J Clin Oncol 35, 2017 (suppl; abstr 7056)

DOI

10.1200/JCO.2017.35.15_suppl.7056

Abstract #

7056

Poster Bd #

256

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

Survival outcomes of primary myelodysplastic syndrome in United States.

Survival outcomes of primary myelodysplastic syndrome in United States.

First Author: Guru Subramanian Guru Murthy

First Author: Amer Methqal Zeidan

First Author: Jason Alan Chesney

First Author: Amer M Zeidan